Overview

Tyler T. Cho, Ph.D., assists clients in intellectual property matters, including drafting and prosecuting U.S. and international patent applications; office action responses and appeals; post-issuance proceedings; and preparing opinions on patentability and/or infringement in a variety of areas, including biotechnology, small molecule pharmaceutical agents and biologics, diagnostic tests, and medical/dental devices.
Tyler specializes in the chemical, pharmaceutical and biotechnological arts. Tyler’s in-depth experience in biochemistry gives him unique insight into various types of patentable products and processes, particularly in the health and biosciences sector. His specialties include:
  • Vaccines (including flaviviruses (e.g. dengue, Zika, yellow-fever etc.) alphaviruses (e.g. chikungunya, Eastern equine encephalitis etc.), enterovirus and poxvirus)
  • Vaccine compositions and methods for administration  
  • Stem cells and stem cell therapy
  • Collagens and microgels 
  • Small molecule pharmaceuticals and biologics
  • Drug targeting/delivery systems
  • Plant genetics and GMO traits 
  • Insecticides, fungicides and herbicides 
  • Transplantation and ischemia/reperfusion injury
  • Gene editing and CRISPR technology

Biosciences Research Experience

Before attending law school, Tyler served as a post-doctoral research fellow at University of Toronto, where his research focused on regulation of SHP-2, a tyrosine phosphatase, related pathways in various types of human cancers and down syndromes. His experience includes developing and analyzing mammalian stem cell and genetically modified mouse model systems.
 
Tyler earned his Ph.D. at Queen's University in Canada, where he identified a new role of LDL-like lipoproteins and apolipoproteins in various cardiovascular diseases.

Credentials

Bar Admissions

Indiana
U.S. Patent and Trademark Office

Languages

Korean

Education

The John Marshall Law School
J.D. cum laude, The John Marshall Review of Intellectual Property Law (articles editor) (2014)

Queen's University
Ph.D. Biochemistry (2009)

Queen's University
B.S. Biochemistry (2003)

Insights & Events

Other Perspectives
  • CRISPR Technology and Related Patent Disputes: Implications and Considerations
    Indiana University Research and Technology Corporation (IURTC), March 13, 2018
  • Reverse Payment Settlements: Not Antitrust Violations Per Se but Subject to Extensive Fact-Based Analyses
    The John Marshall Review of Intellectual Property Law, 2013
  • Apolipoprotein(a) Stimulates Nuclear Translocation of B-catenin: A Novel Pathogenic Mechanism for Lipoprotein(a)
    Molecular Biology of the Cell, 2012
  • SHP2 Tyrosine Phosphatase Converts Parafibromin/Cdc 73 from a Tumor Suppressor to an Oncogenic Driver
    Molecular Cell, 2011
  • Apolipoprotein(a), Through Its Strong Lysine-Binding Site in KIV10, Mediates Increased Endothelial Cell Contraction and Permeability Via a Rho/Rho Kinase/MYPT1-Dependant Pathway
    Journal of Biological Chemistry, 2008
  • The Apolipoprotein(a) Component of Lipoprotein(a) Stimulates Actin Stress Fiber Formation and Loss of Cell-Cell Contact in Cultured Endothelial Cell
    Journal of Biological Chemistry, 2004

Leadership & Community

Professional Associations

  • Korean American Bar Association of Chicago
  • The Korean-American Scientists and Engineers Association (KSEA)

Honors

  • AIPLA Giles S. Rich Memorial Moot Court Competition Team
  • Moot Court Honors Council
  • CALI Excellence for the Future Award — Torts and Corporations
  • Faegre Baker Daniels — Pro Bono Honor Roll, 2015
The Faegre Baker Daniels website uses cookies to make your browsing experience as useful as possible. In order to have the full site experience, keep cookies enabled on your web browser. By browsing our site with cookies enabled, you are agreeing to their use. Review Faegre Baker Daniels' cookies information for more details.